Hydroxy-Vit

Hydroxocobalamin, the active ingredient in Hydroxy-Vit, is a Vitamin B12 (cobalamin) presented as an injectable solution for intramuscular use. It restores deficient vitamin B12 levels and is employed in the management of vitamin B12 deficiency, pernicious anemia, and related megaloblastic anemias.

GNH USA supplies Hydroxy-Vit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable cold‑chain logistics for injectable products. Customers benefit from comprehensive regulatory support and timely delivery across multiple continents.

Hydroxocobalamin is used to treat conditions related to vitamin B12 deficiency and associated hematologic disorders.

- Vitamin B12 deficiency: restores normal B12 levels and improves related symptoms. - Pernicious anemia: corrects the underlying cobalamin lack and supports red blood cell production. - Megaloblastic anemia due to B12 deficiency: promotes DNA synthesis and normalizes marrow activity. - Malabsorption syndromes: provides a parenteral route to bypass gastrointestinal absorption defects.

Adverse reactions may occur following intramuscular administration of hydroxocobalamin.

Common Side Effects: - Pain or bruising at the injection site. - Mild rash or erythema. - Headache. - Nausea. - Dizziness.

Serious or Rare Side Effects: - Anaphylactic reaction. - Severe hypotension. - Hemolytic anemia. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Acute renal impairment.

Hydroxocobalamin should be used with attention to patient history and handling requirements. - Allergy assessment: avoid use in patients with known hypersensitivity to hydroxocobalamin or other cobalamin products. - Renal impairment: monitor closely as reduced clearance may increase systemic exposure. - Pregnancy: consider only if the potential benefit outweighs any unknown risk; data are limited. - Concurrent cyanide exposure: hydroxocobalamin may interfere with certain laboratory assays. - Administration technique: inject deep into muscle using aseptic technique. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Hydroxocobalamin may interact with other medications or substances that affect cobalamin metabolism.

Major Interactions (Avoid): - Sodium nitrite therapy for cyanide poisoning: concurrent use may reduce nitrite efficacy. - High‑dose nitrous oxide exposure: can exacerbate functional B12 deficiency.

Moderate Interactions (Monitor Closely): - Metformin: may lower serum B12; monitor levels during therapy. - Proton pump inhibitors or H2‑blockers: may reduce oral B12 absorption, though less relevant for injectable form. - Antacids containing aluminum or magnesium: monitor for potential additive effects on B12 status.